{"id":"cupressus-arizonica","safety":{"commonSideEffects":[{"rate":null,"effect":"Oral pruritus"},{"rate":null,"effect":"Throat irritation"},{"rate":null,"effect":"Local swelling"},{"rate":null,"effect":"Allergic reactions"}]},"_chembl":null,"_dailymed":{"setId":"97e5c6c0-7101-49b7-8ac4-9dfc60f60cc5","title":"ANIMAL ALLERGENS, AP CATTLE HAIR AND DANDER (CATTLE HAIR AND DANDER) INJECTION, SOLUTION ANIMAL ALLERGENS, AP DOG HAIR AND DANDER CANIS SPP (ANIMAL ALLERGENS, DOG DANDER CANIS SPP) INJECTION, SOLUTION ANIMAL ALLERGENS, DOG HAIR AND DANDER CANIS SPP. (DOG HAIR CANIS SPP.) INJECTION, SOLUTION ANIMAL ALLERGENS, AP HORSE HAIR AND DANDER (AP HORSE HAIR .......CTION, SOLUTION POLLENS - TREES, MULBERRY MIX (MULBERRY MIX) INJECTION, SOLUTION POLLENS - TREES, OAK MIX (OAK MIX) INJECTION, SOLUTION POLLENS - TREES, OAK, RED QUERCUS RUBRA (OAK, RED QUERCUS RUBRA) INJECTION, SOLUTION ANIMAL ALLERGENS, UF DOG HAIR-DANDER CANIS SPP (ANIMAL ALLERGENS, DOG DANDER CANIS SPP) INJECTION, SOLUTION [JUBILANT HOLLISTERSTIER LLC]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This botanical extract contains allergenic proteins from Arizona cypress pollen. When administered therapeutically, it is believed to induce immune tolerance through mechanisms such as T-regulatory cell expansion and shift from Th2 to Th1/Treg responses, reducing allergic symptoms upon natural pollen exposure. It is typically used in sublingual or subcutaneous immunotherapy formulations.","oneSentence":"Cupressus arizonica pollen extract acts as an allergen immunotherapy agent that desensitizes the immune system to cypress pollen allergens through gradual exposure.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T03:30:01.626Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Allergic rhinitis and/or allergic asthma caused by Cupressus arizonica (Arizona cypress) pollen sensitization"}]},"trialDetails":[{"nctId":"NCT05533385","phase":"NA","title":"Juniperus Oxycedrus and Cupressus Arizonica Allergen Extracts Standardisation.","status":"COMPLETED","sponsor":"Inmunotek S.L.","startDate":"2023-10-10","conditions":"Allergy Pollen, Allergic Reaction, Allergic Skin Reaction","enrollment":30},{"nctId":"NCT02512653","phase":"PHASE2","title":"Biological Standarization of Cupressus Arizonica Allergen Extract to Determine the Biological Activity in Histamine Equivalent Units (HEP)","status":"COMPLETED","sponsor":"Laboratorios Leti, S.L.","startDate":"2015-11","conditions":"Allergy to Tree Pollen","enrollment":33},{"nctId":"NCT02069535","phase":"PHASE2","title":"An Open Trial to Assess the Tolerability of AVANZ® Cupressus Immunotherapy","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2014-04","conditions":"Allergic Rhinoconjunctivitis","enrollment":52}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":95,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Cupressus arizonica","genericName":"Cupressus arizonica","companyName":"Laboratorios Leti, S.L.","companyId":"laboratorios-leti-s-l","modality":"Biologic","firstApprovalDate":"","aiSummary":"Cupressus arizonica pollen extract acts as an allergen immunotherapy agent that desensitizes the immune system to cypress pollen allergens through gradual exposure. Used for Allergic rhinitis and/or allergic asthma caused by Cupressus arizonica (Arizona cypress) pollen sensitization.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}